Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy

Published:2010-07 Issue:14 Volume:18 Page:5039-5047
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Zeng Zhao-Sen,He Qiu-Qin,Liang Yong-Hong,Feng Xiao-Qing,Chen Fen-Er,Clercq Erik De,Balzarini Jan,Pannecouque Christophe

Funder

National Natural Science Foundation of China

K.U.Leuven

CHAARM microbicide project

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference21 articles.

1. Evolution of Anti-HIV Drug CandidatesPart 2: Diaryltriazine (DATA) Analogues

2. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases

3. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors

4. From 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to Etravirine (TMC125): Fifteen Years of Research on Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

5. The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis;Chemical Biology & Drug Design;2024-05

2. Study of Quantitative Structure-Activity Relationship (QSAR) of Diarylaniline Analogues as in Vitro Anti-HIV-1 Agents in Pharmaceutical Interest;CHEM METHODOL;2023

3. Diarylpyrimidines and related analogs as antiviral agents;Privileged Scaffolds in Drug Discovery;2023

4. Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors;Medicinal Research Reviews;2021-01-26

5. Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years;Acta Pharmaceutica Sinica B;2020-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3